Yehao Yang
Lishui, 323000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Survival analysis and prognostic factors in advanced NSCLC harboring EGFR PACC mutations: A multicenter retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 10, 2025
Comparative investigation of neoadjuvant chemoimmunotherapy versus perioperative (chemo)immunotherapy in resectable non-small cell lung cancer: a real-world retrospective cohort study.
Journal: Translational lung cancer research
Published: March 15, 2025
A four gene risk score model for prognosis and immune microenvironment insights in small cell lung cancer based on CAF functional-related genes.
Journal: Discover oncology
Published: February 23, 2025
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 22, 2024
Real-world efficacy of PD-1/PD-L1 inhibitors in patients with advanced pulmonary neuroendocrine carcinoma: a single-center analysis.
Journal: Therapeutic advances in medical oncology
Published: April 29, 2024
Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: November 29, 2023
Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 22, 2023
Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges.
Journal: Cancer treatment reviews
Published: November 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026